8C6Q

Fragment screening hit II bound to endothiapepsin

8C6Q の概要

• エントリーDOI: 10.2210/pdb8c6q/pdb
• 分子名称: Endothiapepsin, GLYCEROL, 3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)aniline, ... (4 entities in total)
• 機能のキーワード: fragment, complex, screening, protease, hydrolase
• 由来する生物種: Cryphonectria parasitica (chestnut blight fungus)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 43611.97

構造登録者

Wiese, J.N.,Buehrmann, M.,Mueller, M.P.,Rauh, D. (登録日: 2023-01-12, 公開日: 2023-05-24, 最終更新日: 2024-10-16)

主引用文献

Buhrmann, M.,Kallepu, S.,Warmuth, J.D.,Wiese, J.N.,Ehrt, C.,Vatheuer, H.,Hiller, W.,Seitz, C.,Levy, L.,Czodrowski, P.,Sievers, S.,Muller, M.P.,Rauh, D.
Fragtory: Pharmacophore-Focused Design, Synthesis, and Evaluation of an sp 3 -Enriched Fragment Library.
J.Med.Chem., 66:6297-6314, 2023

PubMed Abstract: Fragment-based drug discovery has played an important role in medicinal chemistry and pharmaceutical research. Despite numerous demonstrated successes, the limited diversity and overrepresentation of planar, sp-rich structures in commercial libraries often hamper the full potential of this approach. Hence, the thorough design of screening libraries inevitably determines the probability for meaningful hits and subsequent structural elaboration. Against this background, we present the generation of an exclusive fragment library based on iterative entry nomination by a specifically designed computational workflow: "Fragtory". Following a pharmacophore diversity-driven approach, we used Fragtory in an interdisciplinary academic setting to guide both tailored synthesis efforts and the implementation of in-house compounds to build a curated 288-member library of sp-enriched fragments. Subsequent NMR screens against a model protein and hit validation by protein crystallography led to the identification of structurally novel ligands that were further characterized by isothermal titration calorimetry, demonstrating the applicability of our experimental approach.

PubMed: 37130057
DOI: 10.1021/acs.jmedchem.3c00187

実験手法

X-RAY DIFFRACTION (1.25 Å)